Cancer treatment medications; prohibit health care providers from using the buy and bill process for purchasing and administering.

HB 1336 prohibits healthcare providers from using the "buy and bill" process for cancer treatment medications. This process allows providers to purchase specialty drugs from distributors, store them in-house, administer them to patients, and bill insurers for reimbursement. The bill directly affects cancer treatment providers who currently use this model for chemotherapy or other cancer drugs. It would have banned this practice for cancer medications starting July 1, 2026, but the bill died in committee on February 3, 2026, and did not advance further.